Dr. Andras Ladanyi, MD, PhD

Dr. Ladanyi practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.

Dr. Ladanyi's NPI, 1467784504, was assigned on January 30, 2010. Dr. Ladanyi graduated from Semmelweis University in 1999. Dr. Ladanyi holds Illinois license 036-127910.

Dr. Ladanyi's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.

Dr. Ladanyi's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. Dr. Ladanyi is also affiliated with Rush Copley Medical Center. The medical group on file is Rush University Internists. Dmand AI also links Dr. Ladanyi to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ladanyi practices, 5 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Ladanyi's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Ladanyi is licensed in Illinois.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Ladanyi treats.

CMS data shows 180 Medicare services from Dr. Ladanyi across 6 procedure codes in 2024, for 107 Medicare patients. Medicare paid $17,601 for them.

CMS counts 107 Medicare patients who saw Dr. Ladanyi in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ladanyi's median patient age at 68, with 92% women.

In 2024, Dr. Ladanyi wrote 53 Medicare Part D claims for 19 patients. 64% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $423 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

Dr. Ladanyi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ladanyi as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Ladanyi, published from 2010 to 2022. 2010 was the busiest year, with 2. The most frequent topics are Ovarian Neoplasms, Cell Line, Tumor and Gene Expression Regulation, Neoplastic. Dr. Ladanyi has published most often in J Clin Invest. Dr. Ladanyi's most frequent co-authors are Ernst Robert Lengyel, MD, Gordon B. Mills, MD, PhD and Iris L. Romero.

CMS Open Payments shows 20 general payments to Dr. Ladanyi from 8 drug and device companies from 2017 to 2025. Education make up the largest share, 70% of the total. Intuitive Surgical, Inc. paid the most, $5,321.

Dr. Ladanyi graduated from Semmelweis University in 1999.

Dr. Ladanyi is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.